Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis

Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis

Background: Evidence for the preferred neoadjuvant therapy regimen in triple-negative breast cancer (TNBC) is not yet established. Methods: Literature search was conducted from inception to February 12, 2022. Phase 2 and 3 randomized controlled trials (RCTs) investigating neoadjuvant therapy for TNB...

Full description

Bibliographic Details
Main Authors: Ying-Yi Lin, Hong-Fei Gao, Xin Yang, Teng Zhu, Xing-xing Zheng, Fei Ji, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Jie-Qing Li, Min-Yi Cheng, Kun Wang
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Breast
Subjects:
Neoadjuvant therapy
Triple-negative breast cancer
Network meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977622001394

Internet

http://www.sciencedirect.com/science/article/pii/S0960977622001394

Similar Items